XML 22 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
¥ in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2021
CNY (¥)
¥ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
CNY (¥)
¥ / shares
shares
Dec. 31, 2019
CNY (¥)
¥ / shares
shares
Statement of Comprehensive Income [Abstract]        
Revenues (including related parties amounts of RMB41,878, RMB28,106 and RMB5,913 for the years ended December 31,2019, 2020 and 2021, respectively) ¥ 752,688 $ 118,113 ¥ 723,453 ¥ 592,798
Cost of revenues (including related parties amounts of RMB7,111, RMB1,414 and nil for the years ended December 31, 2019, 2020 and 2021, respectively) (480,755) (75,441) (478,118) (378,030)
Gross profit 271,933 42,672 245,335 214,768
Operating expenses:        
Selling and marketing expenses (300,043) (47,083) (200,410) (176,009)
General and administrative expenses (385,498) (60,493) (241,356) (102,052)
Impairment loss of goodwill (149,092) (23,396) 0 0
Impairment loss of intangible assets (136) (21)    
Other operating expenses (51,354) (8,059)    
Research and development expenses (including a related party amounts of nil, RMB5,667 and 1,974 for the years ended December 31, 2019, 2020 and 2021, respectively) (297,360) (46,662) (174,192) (167,484)
Total operating expenses (1,183,483) (185,714) (615,958) (445,545)
Operating loss (911,550) (143,042) (370,623) (230,777)
Interest expenses (366) (57) (3,477) (2,077)
Interest income 11,344 1,780 978 992
Investment income     12 114
Share of losses of equity method investments (596) (94)    
Change in fair value of other investments 47,247 7,414 11,614 900
Impairment loss of other investments (6,603) (1,036)    
Change in fair value of warrant liabilities (29,011) (4,552) (61,454) 499
Gain(loss) from disposal of subsidiaries, net 2,899 455 (7,275) 21
Foreign currency exchange gains (losses), net (6,696) (1,051) 6,115 (2,582)
Loss before income taxes (893,332) (140,183) (424,110) (232,910)
Income tax expense (11,120) (1,745) (1,127) (549)
Net loss (904,452) (141,928) (425,237) (233,459)
Net loss attributable to non-controlling interests (593) (93) (5) (16,320)
Net loss attributable to Cloopen Group Holding Limited (903,859) (141,835) (425,232) (217,139)
Accretion and modifications of Redeemable Convertible Preferred Shares (4,878,652) (765,567) (1,139,108) (23,341)
Deemed dividends to Series E Redeemable Convertible Preferred Shareholders     (14,729)  
Net loss attributable to ordinary shareholders (5,782,511) (907,402) (1,579,069) (240,480)
Net loss (904,452) (141,928) (425,237) (233,459)
Other comprehensive income (loss):        
Foreign currency translation adjustment, net of nil income taxes (308,001) (48,332) 153,151 (16,905)
Unrealized loss on available-for-sale investment, net of nil income tax       121
Reclassification adjustment for loss on available-for-sale investment included in net income, net of nil income tax       (114)
Total other comprehensive income (loss) (308,001) (48,332) 153,151 (16,898)
Comprehensive loss (6,091,105) (955,827) (1,425,923) (273,698)
Comprehensive loss attributable to non-controlling interests (593) (93) (81) (16,331)
Comprehensive loss attributable to Cloopen Group Holding Limited ¥ (6,090,512) $ (955,734) ¥ (1,425,842) ¥ (257,367)
Net loss per ordinary share        
- Basic | (per share) ¥ (19.62) $ (3.08) ¥ (18.55) ¥ (2.68)
- Diluted | (per share) ¥ (19.62) $ (3.08) ¥ (18.55) ¥ (2.68)
Weighted average number of ordinary shares outstanding used in computing net loss per ordinary share        
- Basic | shares 294,793,258 294,793,258 85,103,964 89,567,463
- Diluted | shares 294,793,258 294,793,258 85,103,964 89,567,463